Literature DB >> 8893830

Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor.

J E Saavedra1, G J Southan, K M Davies, A Lundell, C Markou, S R Hanson, C Adrie, W E Hurford, W M Zapol, L K Keefer.   

Abstract

Reaction of nitric oxide (NO) with L-proline in methanolic sodium methoxide yields a diazeniumdiolate product, C5H7N3O4Na2.CH3OH (PROLI/NO), that can be stabilized in basic solution but that dissociates to proline (1 mol) and NO (2 mol) with a half-life of only 1.8 s at pH 7.4 and 37 degrees C. This kinetic behavior has allowed the generation of highly localized antiplatelet and vasodilatory effects. By infusing solutions containing 4 microM PROLI/NO in 0.1 M sodium hydroxide at the rate of 1 nmol.min-1 immediately upstream from a polyester vascular graft in the unheparinized baboon circulatory system, for example, platelet deposition at the normally thrombogenic graft surface was substantially reduced relative to controls receiving only 0.1 M sodium hydroxide. In a second study, infusion of PROLI/NO into the right atrium of sheep with induced pulmonary hypertension selectively dilalated the lung vasculature, dose-dependently reducing the pulmonary arterial pressure by as much as 9 mmHg with no observable effect on the systemic arterial pressure at an infusion rate of up to 24 nmol.kg-1.min-1. PROLI/NO could also be formulated as an insoluble polymer blend that released NO smoothly for prolonged periods. The results suggest that localized delivery of diazeniumdiolates such as PROLI/NO which generate NO with extreme rapidity on entering the blood stream may hold considerable promise for inhibition of thrombus formation, selective dilation of the vasculature, and other research and clinical applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893830     DOI: 10.1021/jm960616s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  44 in total

1.  Low NO concentration dependence of reductive nitrosylation reaction of hemoglobin.

Authors:  Jesús Tejero; Swati Basu; Christine Helms; Neil Hogg; S Bruce King; Daniel B Kim-Shapiro; Mark T Gladwin
Journal:  J Biol Chem       Date:  2012-04-04       Impact factor: 5.157

2.  The effect of nitric oxide surface flux on the foreign body response to subcutaneous implants.

Authors:  Scott P Nichols; Ahyeon Koh; Nga L Brown; Michael B Rose; Bin Sun; Danielle L Slomberg; Daniel A Riccio; Bruce Klitzman; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2012-06-27       Impact factor: 12.479

3.  The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline.

Authors:  Sam Y Hong; Gregory L Borchert; Anna E Maciag; Rahul S Nandurdikar; Joseph E Saavedra; Larry K Keefer; James M Phang; Harinath Chakrapani
Journal:  ACS Med Chem Lett       Date:  2010-11-11       Impact factor: 4.345

Review 4.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

5.  Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.

Authors:  Harinath Chakrapani; Michael M Goodblatt; Vidya Udupi; Swati Malaviya; Paul J Shami; Larry K Keefer; Joseph E Saavedra
Journal:  Bioorg Med Chem Lett       Date:  2008-01-04       Impact factor: 2.823

6.  Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

Authors:  Astrid Weyerbrock; Stuart Walbridge; Joseph E Saavedra; Larry K Keefer; Edward H Oldfield
Journal:  Neuro Oncol       Date:  2010-11-01       Impact factor: 12.300

7.  Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1.

Authors:  Wei Qu; Lida Cheng; Anna L Dill; Joseph E Saavedra; Sam Y Hong; Larry K Keefer; Michael P Waalkes
Journal:  Chem Biol Interact       Date:  2011-05-20       Impact factor: 5.192

8.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

Review 9.  Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.

Authors:  R M Pluta
Journal:  Acta Neurochir Suppl       Date:  2008

10.  Glycosylated PROLI/NO derivatives as nitric oxide prodrugs.

Authors:  Rahul S Nandurdikar; Anna E Maciag; Sam Y Hong; Harinath Chakrapani; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2010-01-01       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.